Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.51
+0.06 (1.10%)
Aug 8, 2025, 4:00 PM - Market closed
SpringWorks Therapeutics Revenue
Serina Therapeutics had revenue of $51.00K in the twelve months ending March 31, 2025, down -98.37% year-over-year. In the year 2024, Serina Therapeutics had annual revenue of $56.00K, down -98.22%.
Revenue (ttm)
$51.00K
Revenue Growth
-98.37%
P/S Ratio
1,076.87
Revenue / Employee
$3,923
Employees
13
Market Cap
54.92M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.00K | -3.10M | -98.22% |
Dec 31, 2023 | 3.15M | 2.56M | 433.05% |
Dec 31, 2022 | 591.50K | -2.87M | -82.93% |
Dec 31, 2021 | 3.46M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSER News
- 11 days ago - Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD) - GlobeNewsWire
- 12 days ago - Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference - GlobeNewsWire
- 4 weeks ago - Serina Therapeutics Makes Grant to New Employee Under Inducement Plan - GlobeNewsWire
- 5 weeks ago - Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025 - GlobeNewsWire
- 7 weeks ago - UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42 - GlobeNewsWire
- 7 weeks ago - Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42 - GlobeNewsWire
- 2 months ago - Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?" - GlobeNewsWire